THE C-KIT PROTOONCOGENE IN NORMAL AND MALIGNANT HUMAN HEMATOPOIESIS

被引:0
|
作者
RATAJCZAK, MZ [1 ]
LUGER, SM [1 ]
GEWIRTZ, AM [1 ]
机构
[1] UNIV PENN, SCH MED, DEPT INTERNAL MED, PHILADELPHIA, PA 19104 USA
来源
INTERNATIONAL JOURNAL OF CELL CLONING | 1992年 / 10卷 / 04期
关键词
HEMATOPOIESIS; C-KIT; PROTOONCOGENES; LEUKEMIA; ERYTHROPOIESIS; MYELOPROLIFERATIVE DISORDERS;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The c-kit proto-oncogene encodes a tyrosine kinase receptor (KIT) which is expressed on many types of human cells, including approximately 4% of bone marrow mononuclear cells. Numerous studies attest to the importance of the c-kit receptor and its ligand, known variously as stem cell factor (SCF), mast cell growth factor (MGF), Steel factor (SF), or kit ligand (KL) (the nomenclature we prefer), in the development of human hematopoietic cells. KL, which is produced in membrane-bound and soluble forms by bone marrow stromal cells, acts on pre-colony forming units (pre-CFU) and CFU cells. In synergistic combination with other cytokines, KL enhances the growth of myeloid progenitor cells. However, using an antisense oligodeoxynucleotide strategy to disrupt c-kit function, we have demonstrated that the KL-KIT complex is of greatest importance for generation and/or proliferation of normal human erythropoietic progenitor cells. In malignant hematopoietic cells, the complex also appears to be important for growth of granulocyte/macrophage (GM) CFU as well.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 50 条
  • [1] ROLE OF C-KIT PROTOONCOGENE IN HUMAN INVITRO HEMATOPOIESIS
    RATAJCZAK, M
    SHEN, YM
    GEWIRTZ, A
    CLINICAL RESEARCH, 1991, 39 (02): : A190 - A190
  • [2] ROLE OF THE KIT PROTOONCOGENE IN NORMAL AND MALIGNANT HUMAN HEMATOPOIESIS
    RATAJCZAK, MZ
    LUGER, SM
    DERIEL, K
    ABRAHM, J
    CALABRETTA, B
    GEWIRTZ, AM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) : 1710 - 1714
  • [3] The protooncogene c-kit and c-kit ligand in human disease
    Vliagoftis, H
    Worobec, AS
    Metcalfe, DD
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (04) : 435 - 440
  • [4] Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis
    Escribano, L
    Ocqueteau, M
    Almeida, J
    Orfao, A
    San Miguel, JF
    LEUKEMIA & LYMPHOMA, 1998, 30 (5-6) : 459 - 466
  • [5] Expression of c-kit protooncogene in human hepatocellular carcinoma
    Chung, CY
    Yeh, KT
    Hsu, NC
    Chang, JHM
    Lin, JT
    Horng, HC
    Chang, CS
    CANCER LETTERS, 2005, 217 (02) : 231 - 236
  • [6] CHARACTERIZATION OF THE PROMOTER REGION OF THE HUMAN C-KIT PROTOONCOGENE
    YAMAMOTO, K
    TOJO, A
    AOKI, N
    SHIBUYA, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (11): : 1136 - 1144
  • [7] IDENTIFICATION OF A LIGAND FOR THE C-KIT PROTOONCOGENE
    WILLIAMS, DE
    EISENMAN, J
    BAIRD, A
    RAUCH, C
    VANNESS, K
    MARCH, CJ
    PARK, LS
    MARTIN, U
    MOCHIZUKI, DY
    BOSWELL, HS
    BURGESS, GS
    COSMAN, D
    LYMAN, SD
    CELL, 1990, 63 (01) : 167 - 174
  • [8] EXPRESSION OF THE C-KIT PROTOONCOGENE AND ITS LIGAND STEM-CELL FACTOR (SCF) IN NORMAL AND MALIGNANT HUMAN TESTICULAR TISSUE
    STROHMEYER, T
    REESE, D
    PRESS, M
    ACKERMANN, R
    HARTMANN, M
    SLAMON, D
    JOURNAL OF UROLOGY, 1995, 153 (02): : 511 - 515
  • [9] TRANSIENT ACTIVATION OF TYROSINASE BY C-KIT SCF IN NORMAL AND MALIGNANT HUMAN MELANOCYTES
    LUO, D
    CHEN, H
    DAKOUR, J
    JIMBOW, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (04) : 552 - 552
  • [10] STRUCTURAL ORGANIZATION OF THE MURINE C-KIT PROTOONCOGENE
    GOKKEL, E
    GROSSMAN, Z
    RAMOT, B
    YARDEN, Y
    RECHAVI, G
    GIVOLI, D
    ONCOGENE, 1992, 7 (07) : 1423 - 1429